Ascentage Pharma Group Corporation Competitors, Revenue, Alternatives and Pricing

Claim your profile


Total Funding:N/A
Lead Investor(s):N/A

Estimated Revenue & Financials

  • Ascentage Pharma Group Corporation's estimated annual revenue is currently $20.1M per year.(?)
  • Ascentage Pharma Group Corporation's estimated revenue per employee is $201,000

Employee Data

  • Ascentage Pharma Group Corporation has 100 Employees.(?)
  • Ascentage Pharma Group Corporation grew their employee count by 30% last year.
  • Ascentage Pharma Group Corporation currently has 1 job openings.

Ascentage Pharma is a globally-focused, clinical-stage biopharmaceutical company developing novel small molecule therapies for cancers, hepatitis B and age-related diseases. Based on breakthrough technology from the University of Michigan, the Company's expertise is in designing therapeutics that inhibit protein-protein interactions to restore apoptosis, or programmed cell death, in cancers. Ascentage has built a rich pipeline of six clinical candidates, including a novel, highly potent Bcl-2/Bcl-xL inhibitor, APG-1252, as well as candidates aimed at IAP and MDM2-p53 pathways, and next-generation tyrosine kinase inhibitors. For more information, please visit